Novartis reports topline outcomes from Phase IIIB PNH trial of Fabhalta

Novartis reports topline outcomes from Phase IIIB PNH trial of Fabhalta

Submitted by admin on December 9, 2024 - 10:41am
Source: 
Clinical Trials Arena
News Tags: 
Novartis
Fabhalta
PNH
clinical trials
Headline: 
Novartis reports topline outcomes from Phase IIIB PNH trial of Fabhalta
snippet: 

Novartis has reported positive topline outcomes from the multicentre Phase IIIB APPULSE-PNH trial of oral Fabhalta (iptacopan) for treating adults with paroxysmal nocturnal haemoglobinuria (PNH).

Do Not Allow Advertisers to Use My Personal information